This is a preview of subscription content, log in via an institution to check access.
References
Conard R.A. Late radiation effects in Marshall Islanders exposed to fallout 28 years ago. In: Boice J.D. Jr., Fraumeni J.F. Jr. (Eds.), Radiation carcinogenesis: epidemiology and biological significance. Raven Press, New York, 1984, p. 57.
Hamilton T.E., van Belle G., LoGerfo J.P. Thyroid neoplasia in Marshall Islanders exposed to nuclear fallout. JAMA 258: 629, 1987.
Holm L.-E., Wiklund K.E., Lundell G.E. Cancer risk in population examined with diagnostic doses of 131|. J. Natl. Cancer. Inst. 81: 302, 1989.
Holm L.-E., Wiklund K.E., Lundel G.E. Thyroid cancer after diagnostic doses of iodine-131: a retrospective cohort study. J. Natl. Cancer. Inst. 80: 1132, 1988.
Saenger E.L., Thoma G.E., Tompkins E.A. Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-up Study. JAMA. 205: 855, 1968.
Pochin E.E. Long term hazards of radioiodine treatment of thyroid carcinoma. In: Hedinger C.E. (Eds.), Thyroid cancer. UICC Monograph Series, vol. 12. Springer-Verlag, Berlin, 1969, 293.
Bricker H., Hansen H.S., Andersen A.P. Induction of leukaemia by 131| treatment of thyroid carcinoma. Br J Cancer. 28: 232, 1973.
Hoffman D.A. Late effects of I-131 therapy in the United States. In Boice J.D. Jr, Fraumeni J.F. Jr (Eds.), Radiation carcinogenesis: epidemiology and biological significance. Raven Press, New York, 1984, p. 273.
Edmond C.J., Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br. J. Radiol. 59: 45, 1986.
Goldman M.B., Maloof F., Monson R.R., Aschengrau A., Cooper D.S., Ridgway E.C. Radioactive iodine therapy and breast cancer. A follow-up study of hyperthyroid women. Am. J. Epidemiol. 127: 969, 1988.
Goldman M.B., Monson R.R., Mallof F. Cancer mortality in women with thyroid disease. Cancer Res. 50: 2283, 1990.
Hoffman D.A., McConahey W.M., Diamond E.L., Kurland L.T. Mortality in women treated for hyperthyroidism. Am. J. Epidemiol. 115: 243, 1982.
International Commission on Radiological Protection, radiation dose to patients from radiopharmaceuticals. ICPR Publication 53. Pergamon Press, Oxford, 1988.
Holm L.-E., Hall P., Wiklund K. Cancer risk after iodine-131 therapy for hyperthyroidism. J. Natl. Cancer. Inst. 83: 1072, 1991.
Hall P., Holm L.-E., Lundell G. Cancer risks in thyroid cancer patients. Br. J. Cancer. 64: 159, 1991.
Hall P., Boice JD., Berg G. Leukemia incidence after iodine-131 exposure. Lancet 340: 1, 1992.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hall, P., Holm, L.E. Cancer in iodine-131 exposed patients. J Endocrinol Invest 18, 147–149 (1995). https://doi.org/10.1007/BF03349726
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349726